FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2170862 · Received July 21, 2011

Report

Report Number
2124215-2011-10300
Event Type
Injury
Date Received
July 21, 2011
Date of Event
May 25, 2004
Report Date
July 14, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AT THAT TIME AN INVASIVE EXAMINATION OF THE DEVICE SYSTEM WAS UNREMARKABLE FOR ANY ABNORMALITIES. THE RATE/SENSE IMPEDANCE HAD NORMALIZED. HIGH-ENERGY TESTING CONFIRMED APPROPRIATE DEVICE DETECTION AND THERAPY-DELIVERY, AS WELL AS LEAD IMPEDANCE MEASUREMENTS. NO CHANGES TO THE SYSTEM WERE MADE. ADDITIONAL INFORMATION RECEIVED INDICATES THIS LEAD WAS ATTEMPTED TO BE EXTRACTED DURING A DEVICE CHANGEOUT PROCEDURE. HOWEVER, THE EXTRACTION FAILED AND A PORTION OF THE LEAD PLANNED TO BE RETURNED. AGAIN, IT WAS NOTED THAT THE PACING IMPEDANCES WERE OUT OF RANGE. AT THIS TIME THE LEAD PORTION HAS NOT BEEN RETURNED TO BOSTON SCIENTIFIC, CRM FOR ANALYSIS. THERE IS NO ADDITIONAL INFORMATION AVAILABLE. IF FURTHER INFORMATION BECOMES AVAILABLE, THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE RETURNED LEAD SEGMENT WAS PERFORMED. THE LEAD RETURNED WAS SEVERED 131 MM FROM THE TERMINAL PIN AND ONLY THE PROXIMAL SECTION WAS RETURNED. SET SCREW MARKS WERE NOTED ON ALL TERMINALS, 2 ON EACH. DRIED BLOOD/BODY FLUID WAS ALSO NOTED IN THE RS- LUMEN. ELECTRICALLY, THE LEAD SEGMENT RETURNED WAS CONTINUOUS. ANALYSIS WAS UNABLE TO CONFIRM THE REPORTED CLINICAL OBSERVATION WITH THE LEAD SEGMENT RETURNED.

Description of Event or Problem · 1

GUIDANT RECEIVED INFORMATION APPROXIMATELY (B)(6) AGO THAT THIS IMPLANTABLE TRANSVENOUS DEFIBRILLATION LEAD MEASURED HIGH PACING THRESHOLDS AND AN OUT-OF-RANGE PACING IMPEDANCE OF >3000 OHMS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0157

Patients

Seq Age Sex Outcome Treatment
1 46 YR Life Threatening| R 0157| 1860| 0062| 1600